Attention-deficit hyperactivity disorder.
Jonathan Posner, Guilherme V Polanczyk, Edmund Sonuga-Barke
https://pubmed.ncbi.nlm.nih.gov/31982036Actively Recruiting
Led by Istituto Giannina Gaslini · Updated on 2026-03-17
120
Participants Needed
2
Research Sites
N/A
Total Duration
I
Istituto Giannina Gaslini
Lead Sponsor
I
IRCCS Fondazione Stella Maris
Collaborating Sponsor
Researchers are evaluating ADRIS 2.1, a new driving simulator designed for adolescents aged 13 to 18 years with Attention Deficit Hyperactivity Disorder (ADHD). ADHD is a common neurodevelopmental disorder that impacts attention, self-control, and decision-making, which can affect everyday activities like driving. This study compares driving performance and attention between adolescents with ADHD and those without, aiming to understand how ADHD influences driving behavior and to explore improvements through clinical treatment or training. The study involves both adolescents with ADHD and typically developing peers. Participants will complete cognitive and behavioral assessments and take part in driving simulation sessions using the ADRIS system, which tracks driving errors, body movements, and heart rate. A subgroup of ADHD participants will undergo a 6-week intensive training program with the simulator, while others will be observed without training. Assessments occur at baseline, after 3 months, and following the training period. Participants will attend multiple visits for neuropsychological testing and simulator sessions. The study collects data on driving violations, physiological responses, and cognitive performance to assess attention and impulsivity. Monitoring includes questionnaires and repeated simulator tests to track changes over time. The study aims to provide objective measures that may support future ADHD assessments and interventions, with total participation lasting up to several months depending on group assignment.
CONDITIONS
ADRIS Driving Simulator for Adolescents With Attention Deficit and Hyperactivity Disorder
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo clinical assessments and initial driving simulation sessions to evaluate attention, driving behavior, and cognitive performance using the ADRIS driving simulator and standardized neuropsychological testing.
1 visit (in-person)
Duration - 1 day
ADHD participants repeat the driving simulation session and neuropsychological assessments (excluding cognitive battery) approximately 3 months after baseline to monitor changes following standard clinical treatment.
1 visit (in-person) at 3 months
Duration - 6 weeks
A subgroup of ADHD participants undergo intensive ADRIS simulator training consisting of 12 sessions over 6 weeks to improve attention regulation and driving strategies. Training sessions are conducted twice a week.
12 visits (in-person, twice weekly)
Duration - Before and after the 6-week training period
Participants in the ADRIS training subgroup are evaluated with driving simulation tests and neuropsychological assessments before and after the training period. A control subgroup undergoes the same evaluations without training.
2 visits (in-person)
Total: 2 locations
1
IRCCS Istituto Giannina Gaslini
Genoa, GE, Italy, 16147
Actively Recruiting
2
IRCCS Fondazione Stella Maris
Pisa, PI, Italy, 56128
Actively Recruiting
L
Lino Nobili, MD PhD
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Jonathan Posner, Guilherme V Polanczyk, Edmund Sonuga-Barke
https://pubmed.ncbi.nlm.nih.gov/31982036A Miyake, N P Friedman, M J Emerson...
https://pubmed.ncbi.nlm.nih.gov/10945922Naomi P Friedman, Akira Miyake
https://pubmed.ncbi.nlm.nih.gov/14979754Akira Miyake, Naomi P Friedman
https://pubmed.ncbi.nlm.nih.gov/22773897Anselm B M Fuermaier, Lara Tucha, Ben Lewis Evans...
https://pubmed.ncbi.nlm.nih.gov/26419597Laurence Steinberg
https://pubmed.ncbi.nlm.nih.gov/15668099Russell A Barkley
https://pubmed.ncbi.nlm.nih.gov/9000892R A Barkley, K R Murphy, D Kwasnik
https://pubmed.ncbi.nlm.nih.gov/8951258Joseph Biederman, Ronna Fried, Michael C Monuteaux...
https://pubmed.ncbi.nlm.nih.gov/17263888Ronna Fried, Carter R Petty, Craig B Surman...
https://pubmed.ncbi.nlm.nih.gov/16669721